E box motifs as mediators of proviral latency of human retroviruses
- Jean-Michel Terme†1,
- Sébastien Calvignac†2,
- Madeleine Duc Dodon3Email author,
- Louis Gazzolo3 and
- Albert Jordan1Email author
© Terme et al; licensee BioMed Central Ltd. 2009
Received: 29 April 2009
Accepted: 16 September 2009
Published: 16 September 2009
The palindromic sequence motifs (CANNTG) known as E boxes are considered as binding sites for the basic helix-loop-helix (bHLH) class of DNA-binding proteins. Their presence has been reported in the long terminal repeats (LTR) of the HIV-1 and HTLV-1 proviruses. Their close proximity with the TATA region of both LTRs indicates that the bHLH proteins may act as important regulators of the function of proviral transcription. Indeed, observations on HIV-1 and recent results on HTLV-1 underline that these E boxes may be critically involved in the regulation of the proviral transcription of these human retroviruses. Indeed, of the two E boxes flanking the TATA sequences of the HIV-1 provirus, the 3' E box has been implicated in the transcriptional inhibition of viral gene expression. Such a role might also be played by the unique 5' E box present in the HTLV-1 LTR. In both cases, the expression of tissue-specfic bHLH proteins, like TAL1 might counteract the inhibitory effect exerted by E box proteins, thereby increasing proviral transcription. Finally, a phylogenetic study encompassing several subtypes of these two human retroviruses underlines that these E box motifs have recently appeared in the proviral LTRs and may be considered as potential mediators in the establishment of proviral latency.
The two prototypic human pathogenic retroviruses HIV-1 (Human Immunodeficiency Virus, type 1) and HTLV-1 (Human T cell Leukaemia Virus, type 1) infect their hosts on a long-term basis that relies on their abilities to infect latently specific cellular subsets, such as memory CD4+ T cells. These viruses are thus able to efficiently escape the immune responses as well as the effects of anti-retroviral drugs that are included in highly efficient therapeutic protocols. Consequently, understanding the mechanisms that promote the establishment of latency is critical to the design of future therapies. A promising avenue of investigation is the search for host factors that would decrease proviral transcription. Hence, by considering data on HIV-1 and recent results on HTLV-1, we discuss lines of evidence showing that bHLH proteins may critically intervene in the proviral transcription of these two human retroviruses. Such an intervention is made possible through the presence of E-boxes in the long terminal repeats (LTRs) of the respective provirus.
The consensus hexanucleotide sequence known as the E-box motif (5'-CANNTG-3') represents the core DNA sequence capable of binding the basic helix-loop-helix (bHLH) class of proteins [1, 2]. These proteins contain a basic DNA-binding region juxtaposed to the HLH domain that functions in protein dimerization. bHLH proteins include ubiquitous (class I, e.g. E47) and tissue-specific (class II, e.g. TAL1) transcription factors and play a prominent role in regulatory networks that control a diversity of processes from cell proliferation to cell differentiation. They can form homodimers or heterodimers with class II bHLH proteins and can act as transcriptional activators or repressors through the recruitment of distinct co-activator or co-repressor complexes, respectively [2, 3]. Accordingly, the presence of E boxes in the LTRs of HIV-1 and HTLV-1 underlines the possible intervention of bHLH proteins in regulating proviral transcription.
E box motifs in the LTR of human retroviruses
Indeed, four E box motifs have been described in the LTR of HIV-1; two are located 11 base pairs (bp) upstream and 6 bp downstream of the TATA sequence [4, 5]. These two palindromic sequence motifs (CAGATG and CAGCTG) have been referred to as the 5' E box and the 3' E box, respectively . More recently, the presence of a unique E box sequence (CATATG) in the LTR of HTLV-1, located 28 bp upstream the TATA box, has been reported . The close proximity of these E boxes to the TATA region appears to be specific to the LTRs of HIV-1 and HTLV-1. In the 5' LTR of bovine leukemia virus, (an HTLV-1 related retrovirus), three E box motifs overlapping the cyclic AMP responsive elements (CREs) have been shown to be involved in transcriptional repression of BLV basal gene expression .
Disruptive mutagenesis experiments have underlined the functional importance of the TATA sequences and the flanking E boxes of the HIV-1 LTR, and more particularly of the 3' E box in regulating basal and Tat-induced gene expression . Thus, it has been observed that one natural clone of HIV-1 carrying two mutated E boxes exhibited a high LTR basal activity in U937 cells . More interestingly, experiments have been performed to characterize the bHLH proteins that bind to these E boxes in order to determine their role in the regulation of proviral transcription. Gel retardation analysis demonstrated that the specific binding of E box proteins (as either E47 homodimers or HEB homodimers or HEB/E47 heterodimers), and AP-4, a bHLH-ZIP protein, to the 3' E box of HIV-1 LTR [4, 5]. Recently, the binding of AP-4 (and possibly other bHLH proteins) to the 3' E box was found to exclude the binding of TATA-binding proteins (TBP) to the TATA box and to inhibit the LTR-mediated transcription of the HIV-1 provirus in vitro [4, 9]. Consequently, E boxes in the LTR may account for a modulation of viral replication, and even for the establishment and maintenance of latency in HIV-1 infected cells. The presence of an E box motif in the LTR of HTLV-1 and the observation that E47 was repressing both basal and Tax-induced LTR activity suggest that this bHLH protein indeed favors HTLV-1 proviral latency, possibly by interfering with the binding of TBP to the proximal TATA element . The functional significance of the HTLV-1 putative E box has not been assessed yet. However, the above observations suggest that these E boxes are able to mediate the effect of bHLH proteins on the LTR activity of human retroviruses. Of interest, the overlap of E box elements and CREs in the BLV LTR has been proposed as a strategy to allow better silencing of viral transcription. In this model, suppression of viral gene expression has been shown to contribute not only to the impairment of immune surveillance, but also to the onset and progression of lymphoid tumours in BLV-infected sheep .
Evolutionary significance of E box motifs in the LTR of human retroviruses
As outlined above, the functionality of the E box elements needs further experimental evidence. Nevertheless, one can already address their evolutionary significance through the analysis of their distribution and conservation in LTRs of retroviruses that infect individuals, populations and species. Indeed such an analysis might provide valuable information on their involvement as mediators of proviral latency and on the evolutionary significance of the mechanisms highlighted above. At the scale of one to a few individuals, nearly all HIV-1 quasispecies exhibit intact E boxes (85 to 100% of intact E boxes) [8, 17, 18]. At a larger phylogenetic scale, E box mutants are strictly restricted to HIV-1 subgroups E, F and G (most virological studies have been performed with subtype B isolates) . Interestingly, isolates of subtypes E and G while accounting for less than 9% of all HIV-1 infections were found to display a two- to three-fold higher LTR basal activity than those of subtype B, consistent with a role of the intact E box in decreasing viral expression [19, 20]. Thus, the presence of intact E boxes in the HIV-1 LTR might account for a mechanism that regulates HIV-1 gene expression, as well as proviral latency.
Even if HIV-1 and HTLV-1 have distinct characteristics and strategies to survive in the infected T cells, the capacities of these two human retroviruses to establish a latent infection is considered to be crucial for their pathogenesis. HIV-1 latency has been described to occur at both pre-integration and post-integration levels in infected CD4+ T lymphocytes [23–25]. More specifically, the presence of E box motifs in the HIV-1 LTR has been reported several years ago and raised their implication in the transcriptional regulation of the provirus. The E boxes in the LTR of HIV-1 might represent the binding sites of positively- and negatively-acting bHLH factors that arbitrate between episodes of active viral transcription and silenced gene expression . Under these conditions, it is expected that bursts of viral replication will expose infected cells to the host's immune response, and lead to the gradual depletion of the CD4+ T-cell compartment, favoring immunodeficiency. Concerning HTLV-1, the primary infection is considered as a two-step process involving a transient step of reverse transcription followed by the Tax-induced polyclonal proliferation of infected cells, during genetic instability occurs . Consequently, its is possible that E box proteins (and particularly E47) could contribute to decreased and silenced proviral transcription, that may favor the selection of a restricted number of latently-infected clones that escape the immune response and survive the genomic insults. Thus, proviral silencing might significantly contribute to the initiation of the leukemogenic process, during which the emergence of epigenetic events, such as LTR methylation [27, 28], would in turn favor the long-term suppression of LTR activity. Finally and more importantly, evolutionary considerations also point out the potential importance of these E box motifs in the LTRs of HIV-1 and HTLV-1. Clearly, they plead for further functional investigation of the mechanisms involved in the recruitment of bHLH proteins to the E boxes and of the importance of these motifs as mediators of proviral latency.
We are grateful to P. Jalinot and A. Calvignac-Spencer for helpful discussions. This work was supported by "Association pour la Recherche sur le Cancer, by the "Comité du Rhône de la Ligue Nationale contre le Cancer", by the Fondation pour la Recherche Médicale and by Fondation de France (Comité Leucémie).
- Massari ME, Murre C: Helix-loop-helix proteins: regulators of transcription in eucaryotic organisms. Mol Cell Biol. 2000, 20: 429-440. 10.1128/MCB.20.2.429-440.2000.PubMed CentralView ArticlePubMedGoogle Scholar
- Slattery C, Ryan MP, McMorrow T: E2A proteins: regulators of cell phenotype in normal physiology and disease. Int J Biochem Cell Biol. 2008, 40: 1431-1436. 10.1016/j.biocel.2007.05.014.View ArticlePubMedGoogle Scholar
- Kee BL: E and ID proteins branch out. Nat Rev Immunol. 2009, 9: 175-184. 10.1038/nri2507.View ArticlePubMedGoogle Scholar
- Ou SH, Garcia-Martinez LF, Paulssen EJ, Gaynor RB: Role of flanking E box motifs in human immunodeficiency virus type 1 TATA element function. J Virol. 1994, 68: 7188-7199.PubMed CentralPubMedGoogle Scholar
- Zhang Y, Doyle K, Bina M: Interactions of HTF4 with E-box motifs in the long terminal repeat of human immunodeficiency virus type 1. J Virol. 1992, 66: 5631-5634.PubMed CentralPubMedGoogle Scholar
- Calvignac S, Terme JM, Hensley SM, Jalinot P, Greenwood AD, Hanni C: Ancient DNA identification of early 20th century simian T-cell leukemia virus type 1. Mol Biol Evol. 2008, 25: 1093-1098. 10.1093/molbev/msn054.View ArticlePubMedGoogle Scholar
- Calomme C, Dekoninck A, Nizet S, Adam E, Nguyen TL, Broeke Van Den A, Willems L, Kettmann R, Burny A, Van Lint C: Overlapping CRE and E box motifs in the enhancer sequences of the bovine leukemia virus 5' long terminal repeat are critical for basal and acetylation-dependent transcriptional activity of the viral promoter: implications for viral latency. J Virol. 2004, 78: 13848-13864. 10.1128/JVI.78.24.13848-13864.2004.PubMed CentralView ArticlePubMedGoogle Scholar
- Estable MC, Bell B, Merzouki A, Montaner JS, O'Shaughnessy MV, Sadowski IJ: Human immunodeficiency virus type 1 long terminal repeat variants from 42 patients representing all stages of infection display a wide range of sequence polymorphism and transcription activity. J Virol. 1996, 70: 4053-4062.PubMed CentralPubMedGoogle Scholar
- Imai K, Okamoto T: Transcriptional repression of human immunodeficiency virus type 1 by AP-4. J Biol Chem. 2006, 281: 12495-12505. 10.1074/jbc.M511773200.View ArticlePubMedGoogle Scholar
- Terme JM, Wencker M, Favre-Bonvin A, Bex F, Gazzolo L, Duc Dodon M, Jalinot P: Crosstalk between expression of the HTLV-1 Tax transactivator and the oncogenic bHLH transcription factor TAL1. J Virol. 2008, 82: 7913-22. 10.1128/JVI.02414-07.PubMed CentralView ArticlePubMedGoogle Scholar
- Merimi M, Klener P, Szynal M, Cleuter Y, Bagnis C, Kerkhofs P, Burny A, Martiat P, Broeke Van den A: Complete suppression of viral gene expression is associated with the onset and progression of lymphoid malignancy: observations in Bovine Leukemia Virus-infected sheep. Retrovirology. 2007, 4: 51-10.1186/1742-4690-4-51.PubMed CentralView ArticlePubMedGoogle Scholar
- Xu Z, Meng X, Cai Y, Koury MJ, Brandt SJ: Recruitment of the SWI/SNF protein Brg1 by a multiprotein complex effects transcriptional repression in murine erythroid progenitors. Biochem J. 2006, 399: 297-304. 10.1042/BJ20060873.PubMed CentralView ArticlePubMedGoogle Scholar
- Doyle K, Zhang Y, Baer R, Bina M: Distinguishable patterns of protein-DNA interactions involving complexes of basic helix-loop-helix proteins. J Biol Chem. 1994, 269: 12099-12105.PubMedGoogle Scholar
- Murre C: Helix-loop-helix proteins and lymphocyte development. Nat Immunol. 2005, 6: 1079-1086. 10.1038/ni1260.View ArticlePubMedGoogle Scholar
- O'Neil J, Shank J, Cusson N, Murre C, Kelliher M: TAL1/SCL induces leukemia by inhibiting the transcriptional activity of E47/HEB. Cancer Cell. 2004, 5: 587-596. 10.1016/j.ccr.2004.05.023.View ArticlePubMedGoogle Scholar
- Brooks DG, Kitchen SG, Kitchen CM, Scripture-Adams DD, Zack JA: Generation of HIV latency during thymopoiesis. Nat Med. 2001, 7: 459-464. 10.1038/86531.View ArticlePubMedGoogle Scholar
- Delassus S, Cheynier R, Wain-Hobson S: Evolution of human immunodeficiency virus type 1 nef and long terminal repeat sequences over 4 years in vivo and in vitro. J Virol. 1991, 65: 225-231.PubMed CentralPubMedGoogle Scholar
- Delassus S, Meyerhans A, Cheynier R, Wain-Hobson S: Absence of selection of HIV-1 variants in vivo based on transcription/transactivation during progression to AIDS. Virology. 1992, 188: 811-818. 10.1016/0042-6822(92)90536-X.View ArticlePubMedGoogle Scholar
- Jeeninga RE, Hoogenkamp M, Armand-Ugon M, de Baar M, Verhoef K, Berkhout B: Functional differences between the long terminal repeat transcriptional promoters of human immunodeficiency virus type 1 subtypes A through G. J Virol. 2000, 74: 3740-3751. 10.1128/JVI.74.8.3740-3751.2000.PubMed CentralView ArticlePubMedGoogle Scholar
- Arien KK, Vanham G, Arts EJ: Is HIV-1 evolving to a less virulent form in humans?. Nat Rev Microbiol. 2007, 5: 141-151. 10.1038/nrmicro1594.View ArticlePubMedGoogle Scholar
- Van Dooren S, Verschoor EJ, Fagrouch Z, Vandamme AM: Phylogeny of primate T lymphotropic virus type 1 (PTLV-1) including various new Asian and African non-human primate strains. Infect Genet Evol. 2007, 7: 374-381. 10.1016/j.meegid.2006.06.003.View ArticlePubMedGoogle Scholar
- Coulthart MB, Posada D, Crandall KA, Dekaban GA: On the phylogenetic placement of human T cell leukemia virus type 1 sequences associated with an Andean mummy. Infect Genet Evol. 2006, 6: 91-96. 10.1016/j.meegid.2005.02.001.PubMed CentralView ArticlePubMedGoogle Scholar
- Zamborlini A, Lehmann-Che J, Clave E, Giron ML, Tobaly-Tapiero J, Roingeard P, Emiliani S, Toubert A, de The H, Saib A: Centrosomal pre-integration latency of HIV-1 in quiescent cells. Retrovirology. 2007, 4: 63-10.1186/1742-4690-4-63.PubMed CentralView ArticlePubMedGoogle Scholar
- Han Y, Wind-Rotolo M, Yang HC, Siliciano JD, Siliciano RF: Experimental approaches to the study of HIV-1 latency. Nat Rev Microbiol. 2007, 5: 95-106. 10.1038/nrmicro1580.View ArticlePubMedGoogle Scholar
- Marcello A: Latency: the hidden HIV-1 challenge. Retrovirology. 2006, 3: 7-10.1186/1742-4690-3-7.PubMed CentralView ArticlePubMedGoogle Scholar
- Matsuoka M, Jeang KT: Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat Rev Cancer. 2007, 7: 270-280. 10.1038/nrc2111.View ArticlePubMedGoogle Scholar
- Ishida T, Hamano A, Koiwa T, Watanabe T: 5' long terminal repeat (LTR)-selective methylation of latently infected HIV-1 provirus that is demethylated by reactivation signals. Retrovirology. 2006, 3: 69-10.1186/1742-4690-3-69.PubMed CentralView ArticlePubMedGoogle Scholar
- Taniguchi Y, Nosaka K, Yasunaga J, Maeda M, Mueller N, Okayama A, Matsuoka M: Silencing of human T-cell leukemia virus type I gene transcription by epigenetic mechanisms. Retrovirology. 2005, 2: 64-10.1186/1742-4690-2-64.PubMed CentralView ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.